Comparative effect of vortioxetine and sertraline on clinical and inflammatory profile in Parkinson’s disease with comorbid depression
These data evaluate for the first time the immunomodulatory effects of two different treatments in PD patients with comorbid depression, highlighting the greater immunomodulatory capacity of vortioxetine.
Authors
- Antonella Moschillo (ORCID: https://orcid.org/0000-0002-0518-1686)
- Domiziana Rinaldi (ORCID: https://orcid.org/0000-0002-8011-087X)
- Daniela Caissutti (ORCID: https://orcid.org/0000-0002-5054-8061)
- Edoardo Bianchini (ORCID: https://orcid.org/0000-0001-7955-3369)
- Francesco E. Pontieri (ORCID: https://orcid.org/0000-0002-8693-8432)
- Marika Alborghetti (ORCID: https://orcid.org/0000-0001-9327-6660)
- Fabiana Giada Radicati (ORCID: https://orcid.org/0000-0001-9930-6656)
- Marco Salvetti (ORCID: https://orcid.org/0000-0002-3358-9398)
- Ferdinando Nicoletti
- Antonella Capozzi
- Martina Marino
- Camilla Moliterni
- Isabella Berardelli
Institutions
- Istituto Neurologico Mediterraneo (IT)
- IRCCS Ospedale San Raffaele (IT)
- Sapienza University of Rome (IT)
- Université Grenoble Alpes (FR)
Publication Details
- Journal
- Frontiers in Neuroscience
- Published
- 2026-01-22
- DOI
- https://doi.org/10.3389/fnins.2026.1761550
- Primary Topic
- Tryptophan and brain disorders
- Type
- article
- Field-Weighted Citation Impact
- 0.00